|
|
Volumn 312, Issue 5, 2014, Pages 474-476
|
|
Research on psychiatric disorders targets inflammation
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
CYCLOOXYGENASE 2 INHIBITOR;
INFLIXIMAB;
INTERLEUKIN 6;
NEUROLEPTIC AGENT;
TUMOR NECROSIS FACTOR;
AUTISM;
CELLULAR IMMUNITY;
CLINICAL EFFECTIVENESS;
DISEASE ASSOCIATION;
DISEASE DURATION;
DRUG TARGETING;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOREGULATION;
IMMUNOSTIMULATION;
INFLAMMATION;
MAJOR DEPRESSION;
MEDICAL RESEARCH;
MENTAL DISEASE;
MICROBIOME;
NONHUMAN;
OUTCOME ASSESSMENT;
PARASITE SURVIVAL;
PATHOGENESIS;
PILOT STUDY;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SHORT SURVEY;
TREATMENT RESISTANT DEPRESSION;
TRICHURIS SUIS;
ANTI-INFLAMMATORY AGENTS;
AUTISTIC DISORDER;
CYTOKINES;
DEPRESSION;
HUMANS;
INFLAMMATION;
MENTAL DISORDERS;
SCHIZOPHRENIA;
|
|
EID: 84905922238
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.8276 Document Type: Short Survey |
|
Times cited : (27)
|
|
References (0)
|
